MedPath

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Phase 3
Completed
Conditions
COVID-19
Interventions
Drug: MP0420
Drug: Placebo
Biological: Remdesivir
Registration Number
NCT05780463
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

This study looks at the safety and effectiveness of MP0420 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either MP0420 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H5.

Detailed Description

This is a treatment trial of the ACTIV-3/TICO master protocol (NCT04501978) to evaluate the safety and efficacy of MP0420 in hospitalized patients infected with COVID-19.

This is a randomized, blinded, controlled sub-study of MP0420 plus current SOC against placebo plus current SOC. The placebo arm may be shared across other sub-studies of the ACTIV-3/TICO master protocol. When more than one drug is being tested at the same time, participants will be randomly allocated to treatments or placebo.

Randomization will be stratified by study site pharmacy and disease severity. There are 2 disease severity strata: participants without organ failure (severity stratum 1) and participants with organ failure (severity stratum 2).

An independent Data and Safety Monitoring Board (DSMB) will regularly review interim analyses and summarize safety and efficacy outcomes. The pace of enrollment with be initially restricted, and there will be an early review of safety data by the DSMB. At the outset of the trial, only participants in disease severity stratum 1 will be enrolled. This will continue until approximately 300 participants are enrolled and followed for 5 days. The exact number will vary according to the speed of enrollment and the timing of DSMB meetings. Prior to expanding enrollment to also include patients in disease severity stratum 2, safety will be evaluated and a pre-specified futility assessment by the DSMB will be carried out using 2 ordinal outcomes assessed at Day 5.

If MP0420 passes the futility assessment, enrollment of participants will be expanded, seamlessly and without any data unblinding, to include participants in disease severity stratum 2 as well as those in disease severity stratum 1. Future interim analyses will be based on the primary endpoint of sustained recovery and will use pre-specified guidelines to determine early evidence of benefit, harm, or futility for the investigational agent. Participants will be followed for 18 months following randomization.

This trial will be conducted in several hundred clinical sites. Participating sites are affiliated with networks funded by the United States National Institutes of Health (NIH) and the US Department of Veterans Affairs.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
485
Inclusion Criteria

Refer to the master protocol (NCT04501978)

Read More
Exclusion Criteria

Refer to the master protocol (NCT04501978)

Additional Exclusion Criteria:

  1. Pregnant women
  2. Nursing mothers
  3. Women of child-bearing potential who are unwilling to acknowledge the strong advice to abstain from sexual intercourse with men or practice appropriate contraception through 11 weeks after receiving MP0420/placebo
  4. Men who are unwilling to acknowledge the strong advice to abstain from sexual intercourse with women of child-bearing potential or to use barrier contraception through 11 weeks after receiving MP0420/placebo.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MP0420 plus SOCMP0420* MP0420 600 mg solution (4 vials of 15 mg/mL); administered by IV infusion * Remdesivir is provided to all study participants as SOC unless contraindicated for an individual patient; administered by IV infusion
MP0420 plus SOCRemdesivir* MP0420 600 mg solution (4 vials of 15 mg/mL); administered by IV infusion * Remdesivir is provided to all study participants as SOC unless contraindicated for an individual patient; administered by IV infusion
Placebo plus SOCPlacebo* Placebo administered by IV infusion * Remdesivir is provided to all study participants as SOC unless contraindicated for an individual patient; administered by IV infusion
Placebo plus SOCRemdesivir* Placebo administered by IV infusion * Remdesivir is provided to all study participants as SOC unless contraindicated for an individual patient; administered by IV infusion
Primary Outcome Measures
NameTimeMethod
Number of Participants With Sustained RecoveryThrough Day 90

Sustained recovery defined as being discharged from the index hospitalization, followed by being alive and home for 14 consecutive days prior to Day 90.

Number of Participants With an Ordinal Outcome on Day 5Status on Day 5

Ordinal outcome with 7 mutually exclusive categories

Secondary Outcome Measures
NameTimeMethod
Number of Participants Who Died From All CausesThrough Day 90

All-cause mortality

Number of Participants With a Safety Outcome Through Day 5Through Day 5

Death, SAE, clinical organ failure, serious infections, or Grade 3 or 4 event through Day 5

Number of Participants With a Safety Outcome Through Day 28Through Day 28

Death, SAE, clinical organ failure, serious infections, or Grade 3 or 4 event through Day 28

Number of Participants With a Safety Outcome Through Day 90Through Day 90

Death, SAE, clinical organ failure, serious infections through Day 90

Trial Locations

Locations (105)

Hoag Memorial Hospital Presbyterian (Site 080-026), One Hoag Drive

🇺🇸

Newport Beach, California, United States

Emory University (Site 301-008), The Emory Clinic, Bldg. A, Suite 2236, 1365 Clifton Rd., NE

🇺🇸

Atlanta, Georgia, United States

Lutheran Medical Group (Site 301-010), 7916 W. Jefferson Boulevard

🇺🇸

Fort Wayne, Indiana, United States

University of Maryland Medical Center (Site 301-019), 22 South Greene Street

🇺🇸

Baltimore, Maryland, United States

Michael E. DeBakey Veterans Affairs Medical Center (MEDV AMC) (Site 074-006), 2002 Holcombe Blvd.

🇺🇸

Houston, Texas, United States

VA San Diego Healthcare System (Site 074-016), 3350 La Jolla Village Drive

🇺🇸

San Diego, California, United States

Ronald Reagan UCLA Medical Center (Site 203-002), 757 Westwood Plaza

🇺🇸

Los Angeles, California, United States

Stanford University Hospital & Clinics (Site 203-003), 300 Pasteur Dr.

🇺🇸

Stanford, California, United States

Washington DC VA Medical Center (Site 009-004), 50 Irving Street NW

🇺🇸

Washington, District of Columbia, United States

Baystate Medical Center (Site 201-001), 759 Chestnut Street

🇺🇸

Springfield, Massachusetts, United States

Sacramento VA Medical Center (Site 074-023), 10535 Hospital Way

🇺🇸

Mather, California, United States

Bay Pines VAMC (Site 074-004), 10000 Bay Pines Blvd., Bldg. 100, Room 5B-104

🇺🇸

Bay Pines, Florida, United States

Community Regional Medical Center (Site 203-005), 2823 Fresno Street

🇺🇸

Fresno, California, United States

VA Long Beach Healthcare System (Site 074-026), 5901 East 7th Street (09/151-M2)

🇺🇸

Long Beach, California, United States

Hendrick Medical Center (Site 080-014), 1900 Pine Street

🇺🇸

Abilene, Texas, United States

Democritus University of Thrace (Site 635-021), University General Hospital of Alexandroupolis, Dragana

🇬🇷

Alexandroupolis, Evros, Greece

Carilion Roanoke Memorial Hospital (Site 080-018), 1906 Belleview Avenue

🇺🇸

Roanoke, Virginia, United States

Massachusetts General Hospital (Site 202-002), 55 Fruit Street

🇺🇸

Boston, Massachusetts, United States

Attikon University General Hospital (Site 635-009), 4th Dept. of Internal Medicine, Medical School, National and Kapodistrian University of Athens, 1 Rimini St., Haidari

🇬🇷

Athens, Greece

Wojewódzki Szpital Zakazny (Site 625-302), Wolska 37

🇵🇱

Warsaw, Poland

Tan Tock Seng Hospital (Site 612-201), National Centre for Infectious Diseases (NCID), 11 Jalan Tan Tock Seng

🇸🇬

Singapore, Singapore

Intermountain Medical Center (Site 211-001), 5121 South Cottonwood Street

🇺🇸

Murray, Utah, United States

Swedish Hospital First Hill (Site 208-005), 747 Broadway

🇺🇸

Seattle, Washington, United States

Masaka Regional Referral Hospital (Site 634-606), MRC/UVRI and LSHTM Uganda Research Unit, Plot 6 Circle Road, PO Box 556

🇺🇬

Masaka, Uganda

Salem VA Medical Center (Site 074-014), 1970 Roanoke Blvd.

🇺🇸

Salem, Virginia, United States

3rd Dept. of Medicine, Medical School, NKUA (Site 635-022), Sotiria General Hospital, 152 Mesogeion Ave.

🇬🇷

Athens, Greece

Royal Free Hospital (Site 634-006), Pond Street, Hampstead

🇬🇧

London, United Kingdom

Hospital Del Mar (Site 626-025), Paseo Maritimo 25-29

🇪🇸

Barcelona, Spain

Evangelismos COVID-19 Unit, (Site 635-020), 1st Dept. of Pulmonary and Critical Care Medicine, Evangelismos General Hospital, Dept., Ipsilantou 45-47

🇬🇷

Athens, Greece

CHRISTUS Good Shepherd Medical Center (Site 080-031), 700 E. Marshall Ave.

🇺🇸

Longview, Texas, United States

Guy's and St. Thomas' NHS Foundation Trust (Site 634-011)

🇬🇧

London, United Kingdom

Texas Heart Institute (Site 301-017), 6770 Bertner, MC4-266

🇺🇸

Houston, Texas, United States

Makerere University Lung Institute (Site 634-604), New Mulago Hospital Complex, Mulago Hill

🇺🇬

Kampala, Uganda

University Hospital Zurich (Site 621-201), Department of Infectious Diseases and Hospital Epidemiology, Raemistrasse 100

🇨🇭

Zürich, Zurich, Switzerland

West Virginia University (Site 301-023), One Medical Center Drive

🇺🇸

Morgantown, West Virginia, United States

Institute of Human Virology Nigeria (IHVN) (Site 612-601), Plot 252, Herbert Macaulay Way, Central Business District

🇳🇬

Abuja, Nigeria

Hospital Clínic de Barcelona (Site 626-004), Carrer de Villaroel 170

🇪🇸

Barcelona, Spain

Minneapolis Heart Institute Foundation (Site 301-026), Abbott Northwestern Hospital, 920 E 28th St. #100

🇺🇸

Minneapolis, Minnesota, United States

Hennepin Healthcare (Site 027-001), 701 Park Avenue

🇺🇸

Minneapolis, Minnesota, United States

Minneapolis VA Health Care System (Site 105-001), 1 Veterans Drive, Bldg 70

🇺🇸

Minneapolis, Minnesota, United States

M Health Fairview University of Minnesota Medical Center (Site 112-001), 500 Harvard St. SE.

🇺🇸

Minneapolis, Minnesota, United States

Duke University Hospital (Site 301-006), 2301 Erwin Road

🇺🇸

Durham, North Carolina, United States

St. Francis Hospital, Nsambya (Site 634-607), Nsambya Road Nsambya Hill, P.O. Box 7146

🇺🇬

Kampala, Uganda

Lira Regional Referral Hospital (Site 634-605)

🇺🇬

Lira, Uganda

Gulu Regional Referral Hospital (Site 634-603), Laroo Division, PO Box 160

🇺🇬

Gulu, Uganda

MRC/UVRI and LSHTM Uganda Research Unit (Site 634-601), Entebbe Regional Referral Hospital

🇺🇬

Entebbe, Uganda

Cotton O'Neil Clinical Research Center (Site 080-030), Stormont Vail Health, 1500 SW 10th Avenue

🇺🇸

Topeka, Kansas, United States

UCSF Medical Center at Mount Zion (Site 203-007), 1600 Divisadero St.

🇺🇸

San Francisco, California, United States

San Francisco VAMC (Site 074-002), 4150 Clement St.

🇺🇸

San Francisco, California, United States

Henry Ford Health System, Henry Ford Hospital (Site 014-001), 2799 W. Grand Blvd.

🇺🇸

Detroit, Michigan, United States

VA TVHS Nashville Campus (Site 074-022), 1310 24th Avenue South

🇺🇸

Nashville, Tennessee, United States

1st Respiratory Medicine Dept., Athens University Medical School (Site 635-015), Athens Hospital for Diseases of the Chest "Sotiria Hospital", 152 Mesogeion Ave.

🇬🇷

Athens, Greece

Aalborg Hospital (Site 625-005), Hobrovej 18

🇩🇰

Aalborg, Denmark

Aarhus Universitetshospital, Skejby (Site 625-002), Department of Infectious Diseases, Palle Juul-Hensens Boulevard 99

🇩🇰

Aarhus N, Denmark

Righospitalet (Site 625-006), Blegdamsvej 9,

🇩🇰

Copenhagen Ø, Denmark

Bispebjerg Hospital (Site 625-013), Bispebjerg Bakke 23

🇩🇰

Copenhagen, Denmark

Herlev/Gentofte Hospital (Site 625-012), Medicinsk Afdeling, Herlev Ringvej 75

🇩🇰

Herlev, Denmark

Nordsjællands Hospital (Site 625-009), Dyrehavevej 29

🇩🇰

Hillerød, Denmark

Hvidovre University Hospital, Department of Infectious Diseases (Site 625-001), Kettegård allé 30

🇩🇰

Hvidovre, Denmark

Kolding Sygehus (Site 625-011), Medicinsk Afdeling, Sygehusvej 24

🇩🇰

Kolding, Denmark

Odense University Hospital (Site 625-004), Infektionsmedicinsk Forskningsenhed, J.B. Winsløwsgade 4

🇩🇰

Odense, Denmark

Zealand University Hospital, Roskilde (Site 625-010), Sygehusvej 10

🇩🇰

Roskilde, Denmark

UC Davis Health (Site 203-004), 2315 Stockton Blvd.

🇺🇸

Sacramento, California, United States

Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue

🇺🇸

Tucson, Arizona, United States

Southern Arizona VA Healthcare System (Site 074-009), 3601 S. 6th Ave.

🇺🇸

Tucson, Arizona, United States

Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Blvd.

🇺🇸

Los Angeles, California, United States

Velocity San Diego (Site 080-035), 5565 Grossmont Center Drive, Building 2, Suite 1

🇺🇸

La Mesa, California, United States

MedStar Health Research Institute (Site 009-021), MedStar Washington Hospital Center, 110 Irving St., NW.

🇺🇸

Washington, District of Columbia, United States

Miami VAMC (Site 074-003), 1201 NW 16 Street

🇺🇸

Miami, Florida, United States

West Haven VA Medical Center (Site 025-007), 950 Campbell Avenue

🇺🇸

West Haven, Connecticut, United States

Beth Israel Deaconess Medical Center (Site 202-001), 330 Brookline Ave.

🇺🇸

Boston, Massachusetts, United States

Dartmouth-Hitchcock Medical Center/Mary Hitchcock Memorial Hospital (Site 301-024), One Medical Center Drive

🇺🇸

Lebanon, New Hampshire, United States

Cooper University Hospital (Site 019-001), One Cooper Plaza

🇺🇸

Camden, New Jersey, United States

SUNY Downstate Medical Center (Site 033-001), 450 Clarkson Ave.

🇺🇸

Brooklyn, New York, United States

University Hospitals Cleveland Medical Center (Site 108-001), 11100 Euclid Avenue

🇺🇸

Cleveland, Ohio, United States

Rhode Island Hospital (Site 080-036), 593 Eddy Street

🇺🇸

Providence, Rhode Island, United States

Vanderbilt University Medical Center (Site 212-001), 1211 Medical Center Drive

🇺🇸

Nashville, Tennessee, United States

Hospital Universitari Germans Trias i Pujol (Site 626-003), Infectious Disease Unit, Second Floor, Building Maternal, Road Canyet s/n

🇪🇸

Badalona, Barcelona, Spain

UCSF Medical Center (Site 203-001), Moffitt-Long Hospital, 505 Parnassus Ave.

🇺🇸

San Francisco, California, United States

Velocity Chula Vista (Site 080-034), 752 Medical Center Ct., Ste. 304

🇺🇸

Chula Vista, California, United States

University of Mississippi Medical Center (Site 202-005), 2500 North State Street

🇺🇸

Jackson, Mississippi, United States

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (Site 066-002), 1124 W. Carson Street, CDCRC Building

🇺🇸

Torrance, California, United States

MUSC Health Florence Medical Center (Site 210-006), 805 Pamplico Highway

🇺🇸

Florence, South Carolina, United States

The Miriam Hospital (Site 080-039), 164 Summit Ave.

🇺🇸

Providence, Rhode Island, United States

Maimonides Medical Center (Site 033-002), 4802 10th Avenue

🇺🇸

Brooklyn, New York, United States

University of Cincinnati Medical Center (Site 207-003), 234 Goodman Ave.

🇺🇸

Cincinnati, Ohio, United States

Parkland Health and Hospital Systems (Site 084-002), 5200 Harry Hines Blvd

🇺🇸

Dallas, Texas, United States

CHRISTUS Spohn Shoreline Hospital (Site 080-001), 600 Elizabeth Street

🇺🇸

Corpus Christi, Texas, United States

UT Southwestern Medical Center (Site 084-001), 1936 Amelia Court, 2nd Floor

🇺🇸

Dallas, Texas, United States

Baylor, Scott and White Health (Site 301-003), Baylor University Medical Center, 3500 Gaston Ave.

🇺🇸

Dallas, Texas, United States

University of Virginia Health Systems (Site 301-021), 1215 Lee Street

🇺🇸

Charlottesville, Virginia, United States

Hospital Universitari Arnau de Vilanova (Site 626-035), Av. Alcalde Rovira Roure 80

🇪🇸

Lleida, Leida, Spain

Royal Victoria Infirmary (Site 634-007), Queen Victoria Road

🇬🇧

Newcastle Upon Tyne, Northumbria, United Kingdom

University of Colorado Hospital (Site 204-001), 12605 E. 16th Avenue

🇺🇸

Aurora, Colorado, United States

Denver Public Health (Site 017-004), 660 Bannock St., MC2600 (Infectious Disease Clinic)

🇺🇸

Denver, Colorado, United States

Hillsborough County Health Department, University of South Florida (Site 032-001)

🇺🇸

Tampa, Florida, United States

Ochsner Clinic Foundation (Site 301-015), 1514 Jefferson Highway

🇺🇸

New Orleans, Louisiana, United States

University of Michigan (Site 205-001), 1500 East Medical Center Drive

🇺🇸

Ann Arbor, Michigan, United States

Lincoln Medical Center (New York Health and Hospitals/Lincoln) (Site 003-016), 234 E. 149th Street

🇺🇸

Bronx, New York, United States

Montefiore Medical Center Moses Hospital (Site 206-001), 111 E. 210th Street

🇺🇸

Bronx, New York, United States

Wake Forest University Health Sciences (Site 210-001), Medical Center Blvd

🇺🇸

Winston-Salem, North Carolina, United States

Oregon Health & Science University (Site 208-003), 3181 SW Sam Jackson Park Rd.

🇺🇸

Portland, Oregon, United States

Portland VA Healthcare System (Site 074-024), 3710 SW. US Veterans Hospital Road

🇺🇸

Portland, Oregon, United States

Ralph H. Johnson VA Medical Center (Site 074-015), 109 Bee Street

🇺🇸

Charleston, South Carolina, United States

MUSC Research Nexus Clinic (Site 210-002), 96 Jonathan Lucas St., CSB 214

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath